4-74748115-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001729.4(BTC):c.463G>A(p.Glu155Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000932 in 1,609,806 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001729.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BTC | NM_001729.4 | c.463G>A | p.Glu155Lys | missense_variant | 5/6 | ENST00000395743.8 | |
BTC | NM_001316963.2 | c.316G>A | p.Glu106Lys | missense_variant | 4/5 | ||
BTC | XM_011532211.2 | c.463G>A | p.Glu155Lys | missense_variant | 5/6 | ||
BTC | XM_047416103.1 | c.316G>A | p.Glu106Lys | missense_variant | 4/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BTC | ENST00000395743.8 | c.463G>A | p.Glu155Lys | missense_variant | 5/6 | 1 | NM_001729.4 | P1 | |
BTC | ENST00000512743.1 | c.253G>A | p.Glu85Lys | missense_variant | 3/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000442 AC: 11AN: 248980Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134822
GnomAD4 exome AF: 0.00000823 AC: 12AN: 1457512Hom.: 0 Cov.: 29 AF XY: 0.00000414 AC XY: 3AN XY: 725302
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152294Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74460
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2021 | The c.463G>A (p.E155K) alteration is located in exon 5 (coding exon 5) of the BTC gene. This alteration results from a G to A substitution at nucleotide position 463, causing the glutamic acid (E) at amino acid position 155 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at